Likes
The global Medical Device Packaging Market size is expected to reach USD 48.97 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2020 to 2028. The market growth is attributed to the growing demand for medical devices, such as surgical implants and instruments, medical supplies, electro-medical equipment, and in-vitro diagnostic equipment. The increasing aging population that requires advanced medical treatments, coupled with the unhealthy lifestyles of people, has been resulting in the high prevalence of chronic diseases.
These medical device packaging products are manufactured through various technologies, such as heat seal and sterilization, in order to ensure product safety and convenience in use. Furthermore, several other technologies such as seal peal and counterfeit have been utilized by the manufacturers in order to hinder counterfeit and duplicate products in the market. These counterfeit technologies are also used to track the products and offer complete protection against counterfeiting through unique numbering/ serialization.
The medical device packaging industry is concentrated in the developed countries, including the U.S., Germany, the U.K., and China. due to the large production volumes of medical devices in the aforementioned countries. However, the investments in the medical device industry in developing countries, such as India and Brazil, have been growing in recent years, which is expected to benefit the market growth in the coming years.
In vitro diagnostic (IVD) devices witnessed a massives pike in demand in 2020 amid the COVID-19 outbreak. This was due to the amplified demand for infectious disease tests undertaken by countries, such as the U.S., India, China, and the U.K. The countries significantly invested in COVID-19 testing to curb the spread of the coronavirus.
The key companies operating in the market are involved in the acquisition of medium and small size companies aiming to expand their product portfolio and increase manufacturing capacity. For instance, in October 2020, CCL Industries signed an agreement to acquire Denmark-based Graphic West International ApS. The acquisition was aimed to expand the capability to serve healthcare customers in Europe and North America.
Related Press Release@ Medical Device Packaging Market Report
Medical Device Packaging Market Report Highlights
In terms of material, metal is expected to register the highest growth rate of 7.2% over the forecast period. The aluminum-based boxes, trays, and flexible pouches are prominently used products in the industry and offer an effective barrier against moisture, oxygen, and light
By product, pouches and bags dominated the market with a share of over 35.0% in 2020. This is attributed due to the flexible feature that can accommodate medical devices of various shapes and sizes. Their small size and high product-to-package ratio enable easy storage and handling of medical devices
In terms of application, IVDs are expected to expand at the fastest CAGR from 2020 to 2028 due to the increasing demand for infectious disease diagnostic instruments and reagents. This is due to the high demand for the aforementioned medical devices during the ongoing COVID-19 pandemic
Europe emerged as the dominant regional market in 2020. This is due to the presence of several medical device producers that manufacture IVD test kits, ventilators, and other diagnostic devices in the countries, such as the U.K. and Germany
Key players in the market are involved in mergers and acquisitions and geographical expansions
Be the first person to like this.
The global Vials And Ampoules Market size is anticipated to reach USD 13.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.5% from 2021 to 2028. The market is predominantly driven by the rapid growth in the pharmaceutical industry mainly in emerging markets such as India and China. In addition, the COVID-19 pandemic has created a huge demand for vials and ampoules globally. The production of the COVID-19-vaccine at a large scale in various nations across the globe has significantly impacted the market scenario.
Companies such as Pfizer, Serum Institute of India, among other several biotechnology and pharmaceutical manufacturing companies are consistently doing R&D and developing vaccines with greater efficiency against coronavirus. The government of various nations has aimed to vaccinate the majority of their country’s population by the end of 2021. Thus, vials and ampoules manufacturers are ramping up their production capacity multi-folds. India is among the top worst hit nations in the world. Moreover, the government of India is aiming to vaccinate the majority of the 137 crores Indian population by the end of 2021. This, further accelerate the demand for vials in India.
Various vials and ampoule manufacturing companies such as Schott Kaisha and Gerresheimer India are scaling up their capacity in India. For instance, Gerresheimer India is planning to increase its capacity by 30.0%. Companies are developing hybrid plastic and glass vials and ampoules with increased durability and low cost. Such innovations by the market players are expected further increase their product demand in the global market.
Related Press Release@ Vials And Ampoules Market Report
Vials And Ampoules Market Report Highlights
The glass material segment contributed to a revenue share of 77.5% in 2020. Glass is the most extensively used packaging material in the pharmaceutical industry owing to its properties such as non-reactive, non-corrosive, reusable, and recyclable properties
The plastic segment is anticipated to grow well during the forecast period 2021 - 2028. Plastic vials are cost-effective, durable, and lightweight. Moreover, plastic gives design flexibility. Such factors are increasing the demand for plastic material in the manufacturing of vials and ampoules
India is the second-largest market for ampoules and vials in terms of value in Asia Pacific. This is due to the huge production of generic medicines in India. India is the largest supplier of generic pharmaceutical products in the world. Moreover, the recent outbreak has increased the demand for vials and ampoules in India
Pharmaceutical companies such as Serum Institute of India and Bharat Biotech have developed the COVID-19 vaccines i.e., Covishield and Covaxin. The production of these vaccines is on large scale, which further requires a huge number of vials. Thus, India is one of the major markets for vials and ampoules in recent times
Among the product segment, the ampoules segment accounted for a majority of the revenue share in 2020. Ampoules are low-cost compared to vials. In the pharmaceutical industries and hospitals, doctors normally give 1ml to 3ml of vaccines to a patient which mainly comes in the ampoules format
The key market players are utilizing their full capacity and rapidly increasing their production capacities due to the increasing demand for vials and ampoules in the manufacturing of COVID-19 vaccines. For instance, in November 2020, Schott Kaisha announced an investment of around USD 14 million in its existing production facility to increase the vials production capacity by 300 million pieces
Be the first person to like this.
People Also Like
1
Like
Insurance Company
1
Like
Insurance Company
1
Like
Company
1
Like
Legal/Law
Page Admins
-
sara JamesFounder